202 related articles for article (PubMed ID: 12962944)
1. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?
Olsson H; Bladström A; Ingvar C
Obstet Gynecol; 2003 Sep; 102(3):565-70. PubMed ID: 12962944
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997.
Pukkala E; Tulenheimo-Silfvast A; Leminen A
Cancer Causes Control; 2001 Feb; 12(2):111-5. PubMed ID: 11246839
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L
Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).
Jernström H; Bendahl PO; Lidfeldt J; Nerbrand C; Agardh CD; Samsioe G
Cancer Causes Control; 2003 Sep; 14(7):673-80. PubMed ID: 14575365
[TBL] [Abstract][Full Text] [Related]
7. A population-based cohort study of HRT use and breast cancer in southern Sweden.
Olsson H; Bladström A; Ingvar C; Möller TR
Br J Cancer; 2001 Sep; 85(5):674-7. PubMed ID: 11531250
[TBL] [Abstract][Full Text] [Related]
8. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
10. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and lung cancer risk: a case-control analysis.
Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Risk of stroke and hormone replacement therapy. A prospective cohort study.
Li C; Engström G; Hedblad B; Berglund G; Janzon L
Maturitas; 2006 Apr; 54(1):11-8. PubMed ID: 16321486
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
15. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
16. The influence of hormone replacement therapy on lung cancer incidence and mortality.
Titan AL; He H; Lui N; Liou D; Berry M; Shrager JB; Backhus LM
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1546-1556.e4. PubMed ID: 31866083
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies.
Fernandez E; Gallus S; Bosetti C; Franceschi S; Negri E; La Vecchia C
Int J Cancer; 2003 Jun; 105(3):408-12. PubMed ID: 12704678
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):885-891. PubMed ID: 31919692
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy regimens and breast cancer risk(1).
Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data.
Petitti DB; Buckwalter JG; Crooks VC; Chiu V
J Gerontol A Biol Sci Med Sci; 2002 Aug; 57(8):M532-8. PubMed ID: 12145368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
